Ery-Tab and Exubera

• Generic Name: erythromycin
• Dosage Forms: tablet, delayed release
• Other Brand Names: Ery-Tab, EES. Granules, EES-400 Filmtab, EryPed 200, EryPed 400, Erythrocin Lactobionate, Erythrocin Stearate Filmtab, PCE Dispertab, E. E. S, EryPed, Erythrocin, Erythromycin Filmtabs, Erythromycin Lactobionate - IV

Ery-Tab is a delayed release tablet containing either 250 mg, 333 mg, or 500 mg of erythromycin as the free base. Erythromycin belongs to a group of drugs called macrolide antibiotics. Macrolide antibiotics slow the growth of, or sometimes kill, sensitive bacteria by reducing the production of important proteins needed by the bacteria to survive.

Ery-Tab is used to treat or prevent many different types of infections caused by bacteria.

Ery-Tab may also be used for purposes not listed in this medication guide.

• Generic Name: insulin inhalation, rapid acting
• Dosage Forms: inhalation powder
• Other Brand Names: Exubera, Afrezza, Exubera, EXUBERA Combination Pack 12, EXUBERA Combination Pack 15, EXUBERA Kit, Afrezza 4 unit- 8 unit, Afrezza 8 unit- 12 unit, Afrezza Titration Pack

Insulin inhalation (Exubera) was withdrawn from the U.S. market in 2007 due to lack of consumer demand for the product. No drug safety concerns were cited in this withdrawal.

Exubera is a rapid-acting form of human insulin that is inhaled through the mouth. It works by lowering levels of glucose (sugar) in the blood.

Exubera is used to treat type 1 (insulin dependent) or type 2 (non-insulin dependent) diabetes in adults.